Evidence map›Paper›PMID 31015421›Full record

ArticleNature communications2019

Artificial cell membrane binding thrombin constructs drive in situ fibrin hydrogel formation.

Robert C Deller, Thomas Richardson, Rebecca Richardson, Laura Bevan, Ioannis Zampetakis, Fabrizio Scarpa, Adam W Perriman

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Enzyme-Integrated Hydrogels for Advanced Biological Applications.Polymer science & technology (Washington, D.C.) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Cell augmentation strategies for cardiac stem cell therapies.Stem cells translational medicine · 2021
    Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Robert C DellerSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Thomas RichardsonSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.ORCID http://orcid.org/0000-0001-6900-1093
Rebecca RichardsonSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK.ORCID http://orcid.org/0000-0002-4701-8713
Laura BevanSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK.
Ioannis ZampetakisBristol Composites Institute (ACCIS), University of Bristol, Bristol, BS8 1TR, UK.
Fabrizio ScarpaBristol Composites Institute (ACCIS), University of Bristol, Bristol, BS8 1TR, UK.ORCID http://orcid.org/0000-0002-5470-4834
Adam W PerrimanSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK. chawp@bristol.ac.uk.
University of Bristol · GBUniversity of Liverpool · GB

Funding

Medical Research Council MR/S016430/1
6 · The paper itself

Abstract

Cell membrane re-engineering is emerging as a powerful tool for the development of next generation cell therapies, as it allows the user to augment therapeutic cells to provide additional functionalities, such as homing, adhesion or hypoxia resistance. To date, however, there are few examples where the plasma membrane is re-engineered to display active enzymes that promote extracellular matrix protein assembly. Here, we report on a self-contained matrix-forming system where the membrane of human mesenchymal stem cells is modified to display a novel thrombin construct, giving rise to spontaneous fibrin hydrogel nucleation and growth at near human plasma concentrations of fibrinogen. The cell membrane modification process is realised through the synthesis of a membrane-binding supercationic thrombin-polymer surfactant complex. Significantly, the resulting robust cellular fibrin hydrogel constructs can be differentiated down osteogenic and adipogenic lineages, giving rise to self-supporting monoliths that exhibit Young's moduli that reflect their respective extracellular matrix compositions.

Indexed as

Wound HealingAnimalsAnimals, Genetically ModifiedCell DifferentiationCell EngineeringCell MembraneDisease Models, AnimalElastic ModulusExtracellular MatrixFibrinFibroblastsHumansHydrogelsMesenchymal Stem CellsPolymersRecombinant ProteinsFibrinHydrogelsPolymersrecombinant human thrombinRecombinant ProteinsSurface-Active AgentsThrombin

Identifiers

PMID31015421
PMCPMC6478844
OpenAlexW2940566507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.